A practice game changer: Impact of tenecteplase for acute ischemic stroke in a multicenter quality improvement project
CONCLUSION: Institutions can safely transition from alteplase to tenecteplase as a thrombolytic of choice for AIS.PMID:35037028 | DOI:10.1093/ajhp/zxab482
Source: American Journal of Health-System Pharmacy : AJHP - Category: Drugs & Pharmacology Authors: Lydia Noh Felix Pham Lara Haddad Theresa Burkhard Laurie Paletz Marco Pech Maya Lewis Vicki Manoukian Konrad H Schlick Shlee Song Source Type: research
More News: Activase | Cardiology | Clinical Trials | Drugs & Pharmacology | Heart | Ischemic Stroke | Stroke | Study | Thrombosis